mardi 27 octobre 2015

Onco Actu du 27 octobre 2015

0. A la Une

Australians should limit but not stop red meat intake, say experts [The Guardian]

How Red Meat Joined the 478 Other Things That Might Give You Cancer [Bloomberg]

Red meat is strongly linked to cancer [11 janvier 2005 - Nature News]

WHO report: Red meat linked to cancer – Expert reaction [New Zealand Science Media Centre]

WHO Review Links Red and Processed Meats to Cancer [ACS]

Red Meats Linked to Cancer, Global Health Group Says [Wall Street Journal]

Processed meat and cancer – what you need to know [Cancer Research UK]

Five questions about the WHO’s cancer-causing meat announcement answered [The Globe & Mail]

Italy's Parma ham connoisseurs defend prosciutto amid processed meat scare [The Guardian]

The Guardian view on meat and cancer: a little of what you fancy will do you no harm [The Guardian]

Does bacon cause cancer? Key questions about the WHO red meat report [The Telegraph]

Food industry greets cancer links with a shrug – it's been here before [The Guardian]

Argentinians react to report linking meat to cancer: 'I'd rather die than give it up' [The Guardian]

Processed meat can cause cancer, red meat probably can: WHO [Reuters]

Processed meat: your animated guide to what is a carcinogen - video [The Guardian]

Report Links Some Types of Cancer With Processed or Red Meat [NY Times]

3.1 Tabac

E-cigarettes: a consumer-led revolution [The Guardian]

5. Traitements

Large-scale screen of drug combinations identifies potential treatment for resistant, BRAF-mutant melanoma [Massachusetts General Hospital]

Are progression-free and disease-free survival the new gold standard for cancer trials? [Cancer World]

5.10 Traitements - Essais

Merck's star oncology drug posts mixed results in a lung cancer trial [FierceBiotech]

Merck’s KEYTRUDA® (pembrolizumab) Shows Superior Overall Survival Compared to Chemotherapy in Patients with Previously Treated Advanced Non-Small Cell Lung Cancer Whose Tumors Express PD-L1 [Merck]

Merck's Keytruda extends survival in lung cancer study [Reuters]

5.3 Traitements - FDA, EMA,...

EMA Adopts a Positive Opinion Recommending to Extend Therapeutic Indications for Crizotinib [ESMO]

6. Lutte contre les cancers

First precision medicine centres of excellence announced [Pharma Times]

6.1 Observation

Why People With Metastatic Breast Cancer Want To Get Counted [Forbes]

6.4 Médico-éco

Cancer diagnosis brings income loss for families [Reuters]

6.6 Publications

Auto-Update Has Arrived! ORCID Records Move to the Next Level [ORCID]